Next Arc Research

Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author holds a long position in BWXT.
← Back to Free Index

BWXT

Analysis as of: 2026-02-13
BWX Technologies, Inc.
BWXT manufactures nuclear reactors, nuclear fuel and specialized components and provides nuclear services for U.S. government and commercial customers, including naval propulsion and nuclear medicine.
aerospace defense energy medical devices nuclear
On Yahoo Finance ...
Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

A permissioned nuclear-industrial compounder, priced for execution
Upside comes from converting scarce, qualified nuclear capacity and trust into faster throughput and higher-value services. The main risk is that any quality or funding disruption compresses the premium multiple.

Analysis

Thesis
BWXT can compound as a scarce, permissioned nuclear supplier: convert long-duration U.S. defense/national-security nuclear programs plus commercial services and nuclear medicine into higher throughput and margins, with AI-enabled QA/scheduling improving delivery reliability in a supply-constrained ecosystem.
Last Economy Alignment
Primary moats are trust/permissioning and qualified nuclear capacity (not software); cheaper cognition helps execution, QA evidence, and cycle-time, strengthening its default supplier role.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
2.0x (from 5 most recent analyses)
Reasoning
BWXT’s non-linear upside is execution-driven: nuclear-grade capacity is scarce, and customers value verified on-time delivery more as complexity rises. If BWXT scales constrained programs (naval/national security fuel and processing), integrates services for recurring lifecycle pull, and expands advanced fuel/medical volumes with disciplined capex, it can keep a premium revenue multiple even if it modestly normalizes.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The real tail risks are (1) nuclear trust failure (quality/safety/cyber/compliance), (2) government funding/procurement stop-start delaying awards and cash conversion, and (3) financial flexibility risk if capex + integration costs collide with covenant limits. With the stock already at a scarcity premium, any of these can force a fast multiple reset.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Last Economy Structure

AI Industrial Score
0.72
Upgrade to Reader to also access: Score Decomposition, Confidence Level
Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility
Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target
$199.20
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case